Drug Co-Op Accuses Boehringer Of Mirapex Monopoly
Rochester Drug Co-Operative Inc. has hit Boehringer Ingelheim International GmbH with a putative class action alleging the company took repeated steps, including sham patent litigation and anti-competitive agreements, to unlawfully preserve...To view the full article, register now.
Already a subscriber? Click here to view full article